MYLK2 and CALM1

Number of citations of the paper that reports this interaction (PubMedID 18201104)
5

Data Source:
BioGRID (fluorescent resonance energy transfer)

		MYLK2	CALM1
Description		myosin light chain kinase 2	calmodulin 1
Image
GO Annotations	Cellular Component	Nucleus Cytoplasm Sarcomere Synapse	Spindle Pole Extracellular Region Cell Nucleus Nucleoplasm Cytoplasm Centrosome Cytosol Spindle Microtubule Plasma Membrane Sarcomere Vesicle Protein-containing Complex Calcium Channel Complex Catalytic Complex
	Molecular Function	Calmodulin-dependent Protein Kinase Activity Myosin Light Chain Kinase Activity Protein Binding Calmodulin Binding ATP Binding Myosin Light Chain Binding	Calcium Ion Binding Protein Binding Adenylate Cyclase Binding Adenylate Cyclase Activator Activity Calcium Channel Inhibitor Activity Protein Kinase Binding Protein Domain Specific Binding Enzyme Regulator Activity Titin Binding N-terminal Myristoylation Domain Binding Protein Serine/threonine Kinase Activator Activity Ion Channel Binding Protein Phosphatase Activator Activity Disordered Domain Specific Binding
	Biological Process	Striated Muscle Contraction Neuromuscular Synaptic Transmission Positive Regulation Of Gene Expression Skeletal Muscle Satellite Cell Differentiation Peptidyl-threonine Phosphorylation Regulation Of Muscle Filament Sliding Skeletal Muscle Cell Differentiation Protein Autophosphorylation Cardiac Muscle Tissue Morphogenesis Cardiac Muscle Contraction	MAPK Cascade Microtubule Cytoskeleton Organization Regulation Of Heart Rate Platelet Degranulation Detection Of Calcium Ion Glycogen Catabolic Process Muscle Contraction G Protein-coupled Receptor Signaling Pathway Wnt Signaling Pathway, Calcium Modulating Pathway Positive Regulation Of Peptidyl-threonine Phosphorylation Negative Regulation Of Peptidyl-threonine Phosphorylation Regulation Of Release Of Sequestered Calcium Ion Into Cytosol By Sarcoplasmic Reticulum Regulation Of Cardiac Muscle Contraction By Regulation Of The Release Of Sequestered Calcium Ion Viral Process Calcium-mediated Signaling Substantia Nigra Development Regulation Of Rhodopsin Mediated Signaling Pathway Positive Regulation Of Protein Autophosphorylation Regulation Of Cytokinesis Positive Regulation Of Phosphoprotein Phosphatase Activity Positive Regulation Of Protein Dephosphorylation Fc-epsilon Receptor Signaling Pathway Inositol Phosphate Metabolic Process Regulation Of Nitric-oxide Synthase Activity Cofactor Metabolic Process Positive Regulation Of Cyclic-nucleotide Phosphodiesterase Activity Response To Calcium Ion Regulation Of Cardiac Muscle Contraction Regulation Of Ryanodine-sensitive Calcium-release Channel Activity Negative Regulation Of Ryanodine-sensitive Calcium-release Channel Activity Positive Regulation Of Ryanodine-sensitive Calcium-release Channel Activity Positive Regulation Of Protein Serine/threonine Kinase Activity Regulation Of Cell Communication By Electrical Coupling Involved In Cardiac Conduction
Pathways			CaMK IV-mediated phosphorylation of CREB CaMK IV-mediated phosphorylation of CREB Calmodulin induced events Cam-PDE 1 activation CaM pathway Platelet degranulation Translocation of SLC2A4 (GLUT4) to the plasma membrane Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation PKA activation DARPP-32 events Synthesis of IP3 and IP4 in the cytosol Calcineurin activates NFAT Calcineurin activates NFAT eNOS activation Transcriptional activation of mitochondrial biogenesis Inactivation, recovery and regulation of the phototransduction cascade Inactivation, recovery and regulation of the phototransduction cascade Stimuli-sensing channels FCERI mediated Ca+2 mobilization FCERI mediated Ca+2 mobilization Ca2+ pathway Reduction of cytosolic Ca++ levels Sodium/Calcium exchangers Unblocking of NMDA receptors, glutamate binding and activation CREB1 phosphorylation through the activation of Adenylate Cyclase CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde Ras activation upon Ca2+ influx through NMDA receptor Smooth Muscle Contraction Smooth Muscle Contraction Activation of Ca-permeable Kainate Receptor Uptake and function of anthrax toxins VEGFR2 mediated vascular permeability VEGFR2 mediated cell proliferation Phase 0 - rapid depolarisation Ion homeostasis CLEC7A (Dectin-1) induces NFAT activation CLEC7A (Dectin-1) induces NFAT activation RHO GTPases activate IQGAPs RHO GTPases activate PAKs RHO GTPases activate PAKs RAF activation RAF/MAP kinase cascade Signaling by moderate kinase activity BRAF mutants Signaling by BRAF and RAF fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Glycogen breakdown (glycogenolysis) Glycogen breakdown (glycogenolysis) Protein methylation Extra-nuclear estrogen signaling Loss of phosphorylation of MECP2 at T308 Regulation of MECP2 expression and activity Ion transport by P-type ATPases Negative regulation of NMDA receptor-mediated neuronal transmission Activation of RAC1 downstream of NMDARs Activation of RAC1 downstream of NMDARs Activation of AMPK downstream of NMDARs Long-term potentiation Long-term potentiation Signaling downstream of RAS mutants FCGR3A-mediated IL10 synthesis FCGR3A-mediated IL10 synthesis Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
Drugs		Prenylamine	Chlorpromazine Cinchocaine Nicardipine Fluphenazine Isoflurane Trifluoperazine Loperamide Perphenazine Phenoxybenzamine Felodipine Melatonin Promethazine Pimozide Nifedipine Bepridil Calcium Aprindine 3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine 2-Methyl-2-Propanol N-Trimethyllysine N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide Prenylamine Flunarizine (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE Myristic acid Calcium Citrate Calcium Citrate Calcium Citrate Calcium Phosphate Calcium Phosphate Calcium Phosphate
Diseases
GWAS		Mean corpuscular volume ( 27863252) Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder ( 26184070) Platelet count ( 27863252) Plateletcrit ( 27863252)	Response to platinum-based neoadjuvant chemotherapy in cervical cancer ( 28120872)
Interacting Genes		1 interacting genes: CALM1	246 interacting genes: ACADM ADCY8 ADCYAP1R1 ADD1 ADD2 AKAP5 AKAP6 AKAP9 AR ARHGEF7 ARMC1 ASCL2 ATP2B1 ATRX BRWD1 C11orf65 C4orf3 CABIN1 CALCR CALD1 CAMK1 CAMK2G CAMKK1 CAMKK2 CASP8AP2 CCDC14 CCNA2 CCND1 CCND2 CCNE1 CCP110 CDC37L1 CDC5L CKMT1B CLINT1 CLIP1 CLTB CNGA2 CNN1 CRHR1 CSNK2A1 CSNK2A2 CSNK2B DAPK1 DCTN2 DCUN1D1 DDAH1 DDX21 DDX5 DLG3 DMXL1 DNAJC13 DOCK11 DOCK3 DRD2 DST EDF1 EGFR EIF3C ERBB2 ESR1 ESR2 ESRRG EWSR1 FAS FBXO9 FER FKBP3 FKBP4 GAP43 GCLM GEM GJB1 GLP1R GLP2R GNAS GRB7 GRIN1 GRK1 GRK4 GRK5 GRM3 GRM4 GRM5 GRM7 GTF2I H2AX HERC2 HMMR HSP90AA1 HSPA4 HTR2C HUWE1 IMMT INSR IQCN IQGAP1 IQGAP2 ITGA6 ITPKA ITPKB KCNB1 KCNH1 KCNN2 KCNN3 KCNN4 KCNQ2 KCNQ3 KCNQ5 KDM5C KIF1B KRAS LACTB LINC00839 LMO7 LTF LUC7L LY96 LYST MAPT MATR3 MBIP METAP2 MFHAS1 MIP MORF4L1 MYBPC1 MYC MYCBP2 MYF5 MYF6 MYLK MYLK2 MYO10 MYO5A MYO7A MYO9B MYOD1 MYOG NBR1 NEB NEUROD1 NEXN NOL7 NOS3 NR3C1 NRGN NT5C2 OBSCN OPALIN OPRM1 OPTN PAM PCNT PCP4 PDCD7 PDE1A PHACTR4 PHKB PHKG1 PIK3C3 PLA2G6 PLCD1 POLR2B PPEF1 PPEF2 PPIL2 PRDX1 PSMD12 PSMD2 PTAFR PTEN PTH2R PTPRA PUM3 RAB3B RAD23B RALA RALB RANBP2 RDX REL RELA RGS10 RGS2 RGS4 RIT2 RPL13A RPL22 RPS14 RPS15A RPS4Y1 RPS8 RRAD RS1 RYR1 S100B SCAPER SCLT1 SCN4A SCN5A SCTR SEC61A1 SET SF3B1 SLF2 SLTM SNCA SNRPB2 SNTA1 SNX6 SPP1 SQSTM1 SRP14 SRSF5 STAG1 STIM2 STK38 STRN STRN3 STRN4 STX8 SYK SYNE2 SYT1 TCF3 TCF4 THOP1 TNNI2 TPT1 TRDN TRPC3 TRPV1 TRPV4 TRPV6 TSC2 TTN UBR4 UCHL5 USP16 UTRN VIPR1 XRCC4 YBX1 YWHAE ZBTB24
Entrez ID		85366	801
HPRD ID		05953	00241
Ensembl ID		ENSG00000101306	ENSG00000198668
Uniprot IDs		Q9H1R3	B4DJ51 P0DP23 P0DP24 P0DP25
PDB IDs		2LV6 3KF9	1AJI 1CDL 1CLL 1CTR 1IWQ 1J7O 1J7P 1K90 1K93 1L7Z 1LVC 1NKF 1PK0 1S26 1SK6 1SW8 1UP5 1WRZ 1XFU 1XFV 1XFW 1XFX 1XFY 1XFZ 1Y6W 1YR5 1YRT 1YRU 1ZOT 1ZUZ 2BE6 2F3Y 2F3Z 2HF5 2I08 2JZI 2K0E 2K0F 2K0J 2K61 2KNE 2KUG 2KUH 2L53 2L7L 2LGF 2LL6 2LL7 2LQC 2LQP 2LV6 2M0J 2M0K 2M55 2MG5 2N27 2N6A 2N77 2N8J 2R28 2V01 2V02 2VAY 2W73 2WEL 2X0G 2Y4V 3BYA 3DVE 3DVJ 3DVK 3DVM 3EWT 3EWV 3G43 3HR4 3J41 3O77 3O78 3OXQ 3SUI 3UCT 3UCW 3UCY 4BW7 4BW8 4BYF 4DCK 4DJC 4GOW 4JPZ 4JQ0 4L79 4LZX 4M1L 4OVN 4Q57 4Q5U 4UMO 4UPU 4V0C 5COC 5DBR 5DOW 5DSU 5GGM 5I0I 5J03 5J8H 5JQA 5JTH 5K7L 5K8Q 5NIN 5OEO 5TP5 5TP6 5V02 5V03 5V7X 5VMS 5WBX 5WC5 5WSU 5WSV 6B8L 6B8M 6B8N 6B8P 6B8Q 6BUT 6C1D 6C1G 6C1H 6CNM 6CNN 6CNO 6DAD 6DAE 6DAF 6DAH 6E2F 6E2G 6EEB 6FEG 6FEH 6GDK 6GDL 6HCS 6JI8 6JII 6JIU 6JIY 6JRS 6JV2 6K4K 6K4L 6K4R 6MUD 6MUE 6N5W 6O5G 6PBX 6PBY 6PLM 6S5T
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?